Cost implications to society of delaying childbearing

Expert Review of Obstetrics and Gynecology

Volumn 8, Issue 1, 2013, Pages 9-14

  Hirshfeld Cytron, Jennifer Erin ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

delayed childbearing; fertility preservation; oocyte cryopreservation

Indexed keywords

AGE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; EGG PRODUCTION; FEMALE FERTILITY; FERTILIZATION IN VITRO; HEALTH CARE COST; HUMAN; INFERTILITY THERAPY; MEDICAL TECHNOLOGY; NONHUMAN; OVARIECTOMY; PREGNANCY; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; SOCIAL ASPECT; STRATEGIC PLANNING; VIRILIZATION;

EID: 84871985926     PISSN: 17474108     EISSN: 17474116     Source Type: Journal    
DOI: 10.1586/eog.12.68     Document Type: Review

References (58)

1. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: Mechanisms and clinical consequences. Endocr. Rev. 30(5), 465-493 (2009).
2. Cooke A, Mills TA, Lavender T. 'Informed and uninformed decision making' Y women's reasoning, experiences and perceptions with regard to advanced maternal age and delayed childbearing: A meta-synthesis. Int. J. Nurs. Stud. 47(10), 1317-1329 (2010).
3. Benzies K, Tough S, Tofflemire K, Frick C, Faber A, Newburn-Cook C. Factors influencing women's decisions about timing of motherhood. J. Obstet. Gynecol. Neonatal Nurs. 35(5), 625-633 (2006). (Pubitemid 44874930)
4. Friese C, Becker G, Nachtigall RD. Rethinking the biological clock: Eleventhhour moms, miracle moms and meanings of age-related infertility. Soc. Sci. Med. 63(6), 1550-1560 (2006). (Pubitemid 44108352)
5. Dobrzykowski TM, Noerager Stern P. Out of sync: A generation of first-time mothers over 30. Health Care Women Int. 24(3), 242-253 (2003). (Pubitemid 37414677)
6. Wyndham N, Marin Figueira PG, Patrizio P. A persistent misperception: Assisted reproductive technology can reverse the 'aged biological clock'. Fertil. Steril. 97(5), 1044-1047 (2012).
7. Bromer JG, Patrizio P. Preservation and postponement of female fertility. Placenta 29(Suppl. B), 200-205 (2008).
8. Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N. Engl. J. Med. 360(3), 236-243 (2009).
9. Carolan M, Nelson S. First mothering over 35 years: Questioning the association of maternal age and pregnancy risk. Health Care Women Int. 28(6), 534-555 (2007).
10. Saxell L. Nulliparous women's perception of the risk of pregnancy after age 35. Health Can. Soc. 4(2), 367-387 (1996).
11. Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N. Engl. J. Med. 360(9), 902-911 (2009).
12. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum. Reprod. Update 10(3), 251-266 (2004).
13. Hirshfeld-Cytron J, Gracia C, Woodruff TK. Nonmalignant diseases and treatments associated with primary ovarian failure: An expanded role for fertility preservation. J. Womens. Health (Larchmt.) 20(10), 1467-1477 (2011).
14. Jadoul P, Anckaert E, Dewandeleer A et al. Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence. Fertil. Steril. 96(1), 126-133.e3 (2011).
15. Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil. Steril. 90(5 Suppl), S241-246 (2008).
16. Cobo A, Kuwayama M, Pérez S, Ruiz A, Pellicer A, Remohí J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil. Steril. 89(6), 1657-1664 (2008). (Pubitemid 351749628)
17. Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: A prospective, randomized, controlled, clinical trial. Hum. Reprod. 25(9), 2239-2246 (2010).
18. Parmegiani L, Cognigni GE, Bernardi S et al. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod. Biomed. Online 23(4), 505-512 (2011).
19. Rienzi L, Romano S, Albricci L et al. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: A prospective randomized sibling-oocyte study. Hum. Reprod. 25(1), 66-73 (2010).
20. Hirshfeld-Cytron J, Grobman WA, Milad MP. Fertility preservation for social indications: A cost-based decision analysis. Fertil. Steril. 97(3), 665-670 (2012).
21. Collins J. An international survey of the health economics of IVF and ICSI. Hum. Reprod. Update 8(3), 265-277 (2002). (Pubitemid 34618944)
22. Neumann PJ, Gharib SD, Weinstein MC. The cost of a successful delivery with in vitro fertilization. N. Engl. J. Med. 331(4), 239-243 (1994). (Pubitemid 24226683)
23. Chambers GM, Sullivan EA, Ishihara O, Chapman MG, Adamson GD. The economic impact of assisted reproductive technology: A review of selected developed countries. Fertil. Steril. 91(6), 2281-2294 (2009).
24. Smitz JE, Thompson JG, Gilchrist RB. The promise of in vitro maturation in assisted reproduction and fertility preservation. Semin. Reprod. Med. 29(1), 24-37 (2011).
25. Ubaldi F, Anniballo R, Romano S et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum. Reprod. 25(5), 1199-1205 (2010).
26. Xu M, Barrett SL, West-Farrell E et al. In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum. Reprod. 24(10), 2531-2540 (2009).
27. Xu M, West-Farrell ER, Stouffer RL, Shea LD, Woodruff TK, Zelinski MB. Encapsulated three-dimensional culture supports development of nonhuman primate secondary follicles. Biol. Reprod. 81(3), 587-594 (2009).
28. Donnez J, Jadoul P, Pirard C et al. Live birth after transplantation of frozenYthawed ovarian tissue after bilateral oophorectomy for benign disease. Fertil. Steril. 98(3), 720-725 (2012).
29. Guzman L, Ortega-Hrepich C, Albuz FK et al. Developmental capacity of in vitromatured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm. Fertil. Steril. 98(2), 503-507.e1 (2012).
30. Sánchez F, Romero S, Smitz J. Oocyte and cumulus cell transcripts from cultured mouse follicles are induced to deviate from normal in vivo conditions by combinations of insulin, follicle-stimulating hormone, and human chorionic gonadotropin. Biol. Reprod. 85(3), 565-574 (2011).
31. Romero S, Sánchez F, Adriaenssens T, Smitz J. Mouse cumulus-oocyte complexes from in vitro-cultured preantral follicles suggest an anti-luteinizing role for the EGF cascade in the cumulus cells. Biol. Reprod. 84(6), 1164-1170 (2011).
32. Silber SJ, DeRosa M, Pineda J et al. A series of monozygotic twins discordant for ovarian failure: Ovary transplantation (cortical versus microvascular) and cryopreservation. Hum. Reprod. 23(7), 1531-1537 (2008). (Pubitemid 351809695)
33. Silber SJ, Lenahan KM, Levine DJ et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N. Engl. J. Med. 353(1), 58-63 (2005). (Pubitemid 41007807)
34. Silber SJ. Ovary cryopreservation and transplantation for fertility preservation. Mol. Hum. Reprod. 18(2), 59-67 (2012).
35. Silber SJ, Grudzinskas G, Gosden RG. Successful pregnancy after microsurgical transplantation of an intact ovary. N. Engl. J. Med. 359(24), 2617-2618 (2008).
36. Silber SJ. Fresh ovarian tissue and whole ovary transplantation. Semin. Reprod. Med. 27(6), 479-485 (2009).
37. Donnez J, Dolmans MM, Squifflet J, Kerbrat G, Jadoul P. Live birth after allografting of ovarian cortex between monozygotic twins with Turner syndrome (45,XO/46,XX mosaicism) and discordant ovarian function. Fertil. Steril. 96(6), 1407-1411 (2011).
38. Donnez J, Squifflet J, Pirard C et al. Live birth after allografting of ovarian cortex between genetically non-identical sisters. Hum. Reprod. 26(6), 1384-1388 (2011).
39. Donnez J, Silber S, Andersen CY et al. Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births. Ann. Med. 43(6), 437-450 (2011).
40. Donnez J, Squifflet J, Jadoul P et al. Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation. Fertil. Steril. 95(5), 1787.e1-1787.e4 (2011).
41. Donnez J, Dolmans MM, Pirard C et al. Allograft of ovarian cortex between two genetically non-identical sisters: Case report. Hum. Reprod. 22(10), 2653-2659 (2007). (Pubitemid 47434208)
42. Donnez J, Dolmans MM, Demylle D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364(9443), 1405-1410 (2004). (Pubitemid 39370715)
43. Meirow D, Baum M, Yaron R et al. Ovarian tissue cryopreservation in hematologic malignancy: Ten years' experience. Leuk. Lymphoma 48(8), 1569-1576 (2007). (Pubitemid 47272807)
44. Meirow D, Levron J, Eldar-Geva T et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N. Engl. J. Med. 353(3), 318-321 (2005). (Pubitemid 41058339)
45. Ting AY, Yeoman RR, Lawson MS, Zelinski MB. In vitro development of secondary follicles from cryopreserved rhesus macaque ovarian tissue after slow-rate freeze or vitrification. Hum. Reprod. 26(9), 2461-2472 (2011).
46. Xu J, Lawson MS, Yeoman RR et al. Secondary follicle growth and oocyte maturation during encapsulated threedimensional culture in rhesus monkeys: Effects of gonadotrophins, oxygen and fetuin. Hum. Reprod. 26(5), 1061-1072 (2011).
47. Xu J, Bernuci MP, Lawson MS et al. Survival, growth, and maturation of secondary follicles from prepubertal, young, and older adult rhesus monkeys during encapsulated three-dimensional culture: Effects of gonadotropins and insulin. Reproduction 140(5), 685-697 (2010).
48. van Loendersloot LL, Moolenaar LM, Mol BW, Repping S, van der Veen F, Goddijn M. Expanding reproductive lifespan: A costYeffectiveness study on oocyte freezing. Hum. Reprod. 26(11), 3054-3060 (2011).
49. Rudick B, Opper N, Paulson R, Bendikson K, Chung K. The status of oocyte cryopreservation in the United States. Fertil. Steril. 94(7), 2642-2646 (2010).
50. Hirshfeld-Cytron JE, Mol BW, Goddijn M, Grobman WA, Moolenaar LM, Milad MP. Cost-effective analysis of oocyte cryopreservation Y stunning similarities but differences remain. Hum. Reprod. 27(12), 3639 (2012)
51. Grobman WA. Decision analysis in obstetrics and gynecology. Obstet. Gynecol. Surv. 61(9), 602-607 (2006). (Pubitemid 44325470)
52. Kansal-Kalra S, Milad MP, Grobman WA. In vitro fertilization (IVF) versus gonadotropins followed by IVF as treatment for primary infertility: A cost-based decision analysis. Fertil. Steril. 84(3), 600-604 (2005). (Pubitemid 41317716)
53. Connolly M, Gallo F, Hoorens S, Ledger W. Assessing long-run economic benefits attributed to an IVF-conceived singleton based on projected lifetime net tax contributions in the UK. Hum. Reprod. 24(3), 626-632 (2009).
54. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of costYeffectiveness analysis in health and medicine. Panel on CostYEffectiveness in Health and Medicine. JAMA 276(14), 1172-1177 (1996). (Pubitemid 26329746)
55. Russell LB. The methodologic partnership of effectiveness reviews and costYeffectiveness analysis. Am. J. Prev. Med. 20(3 Suppl), 10-12 (2001). (Pubitemid 33732962)
56. Banta DH, Thacker SB. Historical controversy in health technology assessment: The case of electronic fetal monitoring. Obstet. Gynecol. Surv. 56(11), 707-719 (2001). (Pubitemid 33123691)
57. Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst. Rev. 3, CD006066 (2006)
58. Davies MJ, Moore VM, Willson KJ et al. Reproductive technologies and the risk of birth defects. N. Engl. J. Med. 366(19), 1803-1813 (2012).